The prevalence of allergic rhinitis and atopic markers in obstructive sleep apnea

• Published in: Journal of epidemiology and global health Vol. 7; no. 1; pp. 37 - 44
• Main Authors: Gadi, Ghadah, Wali, Siraj, Koshak, Emad, Albar, Mohammad, Fida, Abdulkareem, Abdelaziz, Muntasir, Alnoury, Khaled, Alama, Nabil
• Format: Journal Article
• Language: English
• Published: Dordrecht Elsevier Ltd 01.03.2017; Springer Netherlands; Springer Nature B.V; Atlantis Press; Springer
• Subjects: Adult; Allergic rhinitis; Apnea; Atopic markers; Atopy; Comorbidity; Cross-Sectional Studies; Diagnosis; Female; Humans; Hypersensitivity, Immediate - epidemiology; Immunoglobulin E; Internal Medicine; Leukocytes (eosinophilic); Male; Middle Aged; Obstructive sleep apnea; Polysomnography; Prevalence; Research Article; Rhinitis, Allergic - epidemiology; Saudi Arabia - epidemiology; Sleep; Sleep apnea; Sleep Apnea, Obstructive - epidemiology; Sleep disorders; Surveys and Questionnaires; Atopic markers; Obstructive sleep apnea; Allergic rhinitis; Atopy
• ISSN: 2210-6006; 2210-6014; 2210-6006
• DOI: 10.1016/j.jegh.2016.06.001

Abstract Allergic rhinitis (AR) related inflammation might worsen the severity of obstructive sleep apnea (OSA), however, the relationship between the two disorders remains controversial. Our aim was to determine the prevalence of AR and atopic markers in OSA. This cross-sectional study recruited participants with sleep-related complaints referred to a sleep center from February 2013 to June 2014. The diagnosis of OSA was based on the Berlin questionnaire (BQ) followed by confirmatory polysomnography (PSG). The diagnosis of AR was made via focused history and clinical examination and was confirmed by measuring atopic markers. OSA was diagnosed in 97 out of 157 adults attending the sleep clinic (61.8%). There was a high prevalence of AR (52.6%) among OSA individuals. This was not significantly different from the frequency in the non-OSA individuals ( p = 0.5). Elevated total immunoglobulin E (IgE; >100 K/μL), eosinophil count, and positive Phadiatop tests were found in individuals with OSA to be 37.1%, 11.3%, and 41.2%, respectively. Individuals without OSA have shown similar percentages. In our cohort, there was no significant difference in frequency of AR and atopy among participants with OSA compared to those without OSA.